Peer Review History

Original SubmissionApril 26, 2024
Decision Letter - Masoud Rahmati, Editor

PONE-D-24-16781Gut microbial composition is altered in sarcopenia: A systematic review and meta-analysis of clinical studiesPLOS ONE

Dear Dr. Chen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 09 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Masoud Rahmati

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the online submission form, you indicated that "The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request."

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Editor

This is a good manuscript reviewing “Gut microbial composition is altered in sarcopenia: A systematic review and metaanalysis of clinical studies”. The subject of the manuscript is fully consistent with the aims and scope of the journal « PLOS ONE». The research methodology is fully consistent with the aims declared by the authors. Their conclusions are also consistent with the set goals, however, some issues need to be reconsidered:

- Please explain all abbreviations in the abstract and manuscript.

Abstracts

- Abstract should be informative, did they have any language and publication preference?

- Keywords: are these keywords are Mesh terms? Word that serves as a keyword, as to the meaning of that condition must be a Mesh term

Introduction

-The authors suggest alpha diversity and they did not explain it, because it need to be explained in the context of gut microbiota; Alpha diversity is crucial in gut microbiota studies because it provides insights into the health and stability of the gut ecosystem. A diverse gut microbiome is often associated with better health outcomes, resilience to infections, and overall well-being, while low diversity can be linked to various diseases and conditions, such as inflammatory bowel disease, obesity, and metabolic disorders.

Methods

- What about other source of potential included articles such as grey literatures? Did the authors searched this references?

Results:

- The figure 1 (flowchart of literature search and review) should be presented as the most updated version of 2020

- Table 1 is not informative; it could summarize included studies data.

Discussion

Authors should also acknowledge some serious limitations of the study:

1. the vast majority of studies originated from Eestern countries; thus, extrapolation of these results to Wastern populations is questionable.

2. significant heterogeneity was encountered perhaps due to various regimens, doses, duration, center settings, populations enrolled etc. calling for cautious interpretation of the results. This is a serious limitation and should be included because it may significantly undermine the validity of results.

3. many of the studies suffer from significant sources of bias and this should be also taken into consideration

4. the effect in many occasions was assessed by very few studies; thus, the evidence to support it is low and should be mentioned.

Authors should also include an Appendix section according to the full PRISMA Guidelines checklist, where respective sections of the manuscript are presented.

-The quality of evidence should be evaluated following the GRADE approach.

Reviewer #2: Dear writers

The gut-muscle axis theory has attracted the attention of researchers in recent years, and conducting a meta-analysis study is necessary for general conclusions. Thank you for choosing this topic.

The manuscript is well written, but revise these points to improve it.

1. It is better to focus on the gut-muscle axis in the introduction of the abstract, instead of reporting the problem of increasing the number of studies in recent years. This is a more attractive start.

2. The abstract of each article should express the study. Your conclusion is very general and it is better to be in the context of the investigated variables in the study and related to the subject.

2. The relationship between intestinal microbiota and muscles, as well as its process in sarcopenia, is not well explained in the introduction. The necessity of this study should be properly reported.

3. The results are reported correctly, but the discussion and conclusions are weak and you could have pointed to more communication mechanisms.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear editors and reviewers:

Thank you for your comments concerning our manuscript entitled “Gut microbial composition is altered in sarcopenia: A systematic review and meta-analysis of clinical studies” (ID: PONE-D-24-16781). Those comments are all valuable and very helpful for revising and improving our paper, as well as the important guiding significance to our researches. We have studied comments carefully and have made correction which we hope meet with approval. The main corrections in the paper and the responds to your comments are as following:

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: According to the journal requirements, we have modified our manuscript’s style.

2.In the online submission form, you indicated that "The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request."

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

Response: Other researchers can find all data underlying the findings described in our manuscript within our manuscript itself.

3.PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

Response: The corresponding author’s account has been linked to an ORCID iD.

4.We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Response: We have removed the phrase “data not shown” since the data are not a core part of the research.

5.Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Response: According to the Supporting Information guidelines, we have listed the supporting information captions at the end of the manuscript in a section titled “Supporting information”.

Reviewer 1

- Please explain all abbreviations in the abstract and manuscript.

Response: Thanks to the reviewer for this comment. After inspecting our manuscript, we have completed some abbreviations without full name (please see line 210-213, 294). Also, we have added explanations of all abbreviations on the title page (please see page 1).

Abstracts

- Abstract should be informative, did they have any language and publication preference?

Response: Thanks to the reviewer for this comment. In order to make our abstract more informative and specific, we have modified the background, the method and the conclusion of the abstract according to the PRISMA 2020 statement. Please see line 35-65.

- Keywords: are these keywords are Mesh terms? Word that serves as a keyword, as to the meaning of that condition must be a Mesh term

Response: According to the reviewer’s suggestion, we used Mesh terms as the keywords. Please see line 66.

Introduction

-The authors suggest alpha diversity and they did not explain it, because it need to be explained in the context of gut microbiota; Alpha diversity is crucial in gut microbiota studies because it provides insights into the health and stability of the gut ecosystem. A diverse gut microbiome is often associated with better health outcomes, resilience to infections, and overall well-being, while low diversity can be linked to various diseases and conditions, such as inflammatory bowel disease, obesity, and metabolic disorders.

Response: Thanks to the reviewer for this comment. Based on your and another reviewer’s suggestions, we have revised the introduction section. Due to limited space and coherence of content, we put the introduction of alpha diversity in the third paragraph, please see line 96-98.

Methods

- What about other source of potential included articles such as grey literatures? Did the authors searched this references?

Response: Thanks to the reviewer for this comment. Currently, we search PubMed using a retrieval formula “((grey literature[Text Word]) AND (meta[Text Word]))” and we find 3,648 records, only accounting for 0.98% (3,648/371,868) of all meta-analyses when using “(meta[Text Word])”. Furthermore, according to a paper published by Hartling et al.,[1] they found that including non-English reports, unpublished studies and dissertations had little impact on results of meta-analyses. Given that there was limited evidence on the contribution of grey literature, we did not include them in our study.

Results:

- The figure 1 (flowchart of literature search and review) should be presented as the most updated version of 2020

Response: According to the reviewer’s suggestion, we have modified the figure 1 using the most updated PRISMA Flow Diagram 2020.

- Table 1 is not informative; it could summarize included studies data.

Response: According to the reviewer’s suggestion, we have added the studies data into the Table 1.

Discussion

Authors should also acknowledge some serious limitations of the study:

1. the vast majority of studies originated from Eestern countries; thus, extrapolation of these results to Wastern populations is questionable.

Response: According to the reviewer’s suggestion, we have added this limitation to the discussion section. Please see line 342-345.

2. significant heterogeneity was encountered perhaps due to various regimens, doses, duration, center settings, populations enrolled etc. calling for cautious interpretation of the results. This is a serious limitation and should be included because it may significantly undermine the validity of results.

Response: According to the reviewer’s suggestion, we have added this limitation to the discussion section. Please see line 345-355.

3. many of the studies suffer from significant sources of bias and this should be also taken into consideration.

Response: Thanks to the reviewer for this comment. As studies included in our systematic review and meta-analysis were cross-sectional, the Joanna Briggs Institute (JBI) critical appraisal checklist for analytical cross-sectional studies was used to assess the methodological quality of included studies. According to the JBI critical appraisal checklist, almost all studies themselves were high in terms of the methodological quality. For differences in patient characteristics and research designs between studies, we have added this limitation to my manuscript on the basis of your previous comment (please see line 345-355).

4. the effect in many occasions was assessed by very few studies; thus, the evidence to support it is low and should be mentioned.

Response: According to the reviewer’s suggestion, we have added this limitation to the discussion section. Please see line 355-357.

Authors should also include an Appendix section according to the full PRISMA Guidelines checklist, where respective sections of the manuscript are presented.

Response: According to the reviewer’s suggestion, we have submitted the PRISMA2020 checklist. Please see S1 Table (line 110-111) in the supplemental file.

-The quality of evidence should be evaluated following the GRADE approach.

Response: Thanks to the reviewer for this comment. We have evaluated the certainty of the body of evidence associated with alpha diversity. Please see the Materials and methods section (line 149-158), the Results section (line 226-228), and the Discussion section (line 352-355).

Reviewer 2

1. It is better to focus on the gut-muscle axis in the introduction of the abstract, instead of reporting the problem of increasing the number of studies in recent years. This is a more attractive start.

Response: Thanks to the reviewer for this comment. We have modified the background of the abstract. Please see Line 36-41.

2. The abstract of each article should express the study. Your conclusion is very general and it is better to be in the context of the investigated variables in the study and related to the subject.

Response: According to the reviewer’s suggestion, we have modified the conclusion of the abstract. Please see Line 61-63.

3. The relationship between intestinal microbiota and muscles, as well as its process in sarcopenia, is not well explained in the introduction. The necessity of this study should be properly reported.

Response: According to the reviewer’s suggestion, we have re-written the introduction. Please see the red font in the introduction.

4. The results are reported correctly, but the discussion and conclusions are weak and you could have pointed to more communication mechanisms.

Response: According to the reviewer’s suggestion, we have re-written the discussion and the conclusion. Please see the red font in both sections.

We tried our best to improve the manuscript and made some changes in the manuscript. We appreciate for Reviewers’ warm work earnestly and hope that the correction will meet with approval. Once again, thank you very much for your comments and suggestions.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Masoud Rahmati, Editor

Gut microbial composition is altered in sarcopenia: A systematic review and meta-analysis of clinical studies

PONE-D-24-16781R1

Dear Dr. Chen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Masoud Rahmati

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Masoud Rahmati, Editor

PONE-D-24-16781R1

PLOS ONE

Dear Dr. Chen,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Masoud Rahmati

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .